Celgene pledges to limit price hikes—or does it?
admin 3rd July 2018 Uncategorised 0Celgene CEO Mark Alles seems to be bowing to pricing pressure with a promise not to hike the company’s prices faster than the projected rise in healthcare inflation. But his pledge has a gaping loophole, raising questions about whether it will apply to cancer blockbuster Revlimid, which has enjoyed some big growth from price hikes.
More: Celgene pledges to limit price hikes—or does it?
Source: fierce